Update: Releasing the Brakes on Antitumor Immune Response
- 22 March 1996
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 271 (5256) , 1691
- https://doi.org/10.1126/science.271.5256.1691
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.The Journal of Experimental Medicine, 1995
- Superantigen-Dependent, Cell-Mediated Cytotoxicity Inhibited by MHC Class I Receptors on T LymphocytesScience, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- A new look for the 1990sNature, 1994
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- Mahmud ʾAmin al-ʿAlim: Between Politics and Literary CriticismPoetics Today, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993